{"id":"https://openalex.org/W4403537544","doi":"https://doi.org/10.1016/j.esmoop.2024.103894","title":"156O Pharmacologic inhibition of nonsense-mediated decay induces anti-tumour immunogenicity in ex vivo patient tumours","display_name":"156O Pharmacologic inhibition of nonsense-mediated decay induces anti-tumour immunogenicity in ex vivo patient tumours","publication_year":2024,"publication_date":"2024-10-01","ids":{"openalex":"https://openalex.org/W4403537544","doi":"https://doi.org/10.1016/j.esmoop.2024.103894"},"language":"en","primary_location":{"id":"doi:10.1016/j.esmoop.2024.103894","doi":"https://doi.org/10.1016/j.esmoop.2024.103894","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2024.103894","pdf_url":"https://www.esmoopen.com/article/S2059-7029(24)01664-8/pdf","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","doaj"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://www.esmoopen.com/article/S2059-7029(24)01664-8/pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033430809","display_name":"Roberto Vendramin","orcid":"https://orcid.org/0000-0001-7191-4887","observed_orcids":["https://orcid.org/0000-0001-7191-4887"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"R. Vendramin","raw_affiliation_strings":["Oncology, UCL Cancer Institute, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, UCL Cancer Institute, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049161563","display_name":"Hongchang Fu","orcid":"https://orcid.org/0009-0003-6582-8554","observed_orcids":["https://orcid.org/0009-0003-6582-8554"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"H. Fu","raw_affiliation_strings":["Oncology, UCL Cancer Institute, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, UCL Cancer Institute, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Y. Zhao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Y. Zhao","raw_affiliation_strings":["Oncology, UCL Cancer Institute, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, UCL Cancer Institute, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105346179","display_name":"Shanila Fernandez Patel","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. Fernandez Patel","raw_affiliation_strings":["Oncology, UCL Cancer Institute, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, UCL Cancer Institute, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048864554","display_name":"Danwen Qian","orcid":"https://orcid.org/0000-0002-6209-0764","observed_orcids":["https://orcid.org/0000-0002-6209-0764"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D. Qian","raw_affiliation_strings":["Oncology, UCL Cancer Institute, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, UCL Cancer Institute, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012632613","display_name":"Lorena Ligammari","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"L. Ligammari","raw_affiliation_strings":["Oncology, UCL Cancer Institute, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, UCL Cancer Institute, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. Levy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"R. Levy","raw_affiliation_strings":["Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5010983199","display_name":"Patricia J. Greenberg","orcid":"https://orcid.org/0000-0001-6652-5019","observed_orcids":["https://orcid.org/0000-0001-6652-5019"]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"P. Greenberg","raw_affiliation_strings":["Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050645298","display_name":"Andrea Castro","orcid":"https://orcid.org/0000-0002-5873-2496","observed_orcids":["https://orcid.org/0000-0002-5873-2496"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. Castro","raw_affiliation_strings":["Oncology, UCL Cancer Institute, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, UCL Cancer Institute, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035638659","display_name":"Krupa Thakkar","orcid":"https://orcid.org/0000-0001-6003-8340","observed_orcids":["https://orcid.org/0000-0001-6003-8340"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"K. Thakkar","raw_affiliation_strings":["Oncology, UCL Cancer Institute, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, UCL Cancer Institute, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":null,"display_name":"J. Murai","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Murai","raw_affiliation_strings":["Oncology, UCL Cancer Institute, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, UCL Cancer Institute, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5060003713","display_name":"Despoina Karagianni","orcid":"https://orcid.org/0000-0002-8605-5808","observed_orcids":["https://orcid.org/0000-0002-8605-5808"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"D. Karagianni","raw_affiliation_strings":["Oncology, UCL Cancer Institute, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, UCL Cancer Institute, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029545367","display_name":"Osnat Bartok","orcid":"https://orcid.org/0009-0005-3306-1007","observed_orcids":["https://orcid.org/0009-0005-3306-1007"]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"O. Bartok","raw_affiliation_strings":["Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027539701","display_name":"Felipe G\u00e1lvez\u2010Cancino","orcid":"https://orcid.org/0000-0001-8417-1891","observed_orcids":["https://orcid.org/0000-0001-8417-1891"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"F. Galvez-Cancino","raw_affiliation_strings":["Oncology, UCL Cancer Institute, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, UCL Cancer Institute, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050558417","display_name":"Eva Camilla Gronroos","orcid":"https://orcid.org/0000-0001-8303-5409","observed_orcids":["https://orcid.org/0000-0001-8303-5409"]},"institutions":[{"id":"https://openalex.org/I2801081054","display_name":"The Francis Crick Institute","ror":"https://ror.org/04tnbqb63","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801081054"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"E.C. Gronroos","raw_affiliation_strings":["Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Evolution and Genome Instability Laboratory, The Francis Crick Institute, London, UK","institution_ids":["https://openalex.org/I2801081054"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012617779","display_name":"Sergio A. Quezada","orcid":"https://orcid.org/0000-0002-9763-1700","observed_orcids":["https://orcid.org/0000-0002-9763-1700"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"S. Quezada","raw_affiliation_strings":["Oncology, UCL Cancer Institute, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, UCL Cancer Institute, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089988286","display_name":"James L. Reading","orcid":"https://orcid.org/0000-0001-5381-978X","observed_orcids":["https://orcid.org/0000-0001-5381-978X"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J.L. Reading","raw_affiliation_strings":["Oncology, UCL Cancer Institute, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, UCL Cancer Institute, London, UK","institution_ids":["https://openalex.org/I45129253"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5042139239","display_name":"Yardena Samuels","orcid":"https://orcid.org/0000-0002-3349-7266","observed_orcids":["https://orcid.org/0000-0002-3349-7266"]},"institutions":[{"id":"https://openalex.org/I53964585","display_name":"Weizmann Institute of Science","ror":"https://ror.org/0316ej306","country_code":"IL","type":"education","lineage":["https://openalex.org/I53964585"]}],"countries":["IL"],"is_corresponding":false,"raw_author_name":"Y. Samuels","raw_affiliation_strings":["Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, Israel"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Molecular Cell Biology Department, Weizmann Institute of Science, Rehovot, Israel","institution_ids":["https://openalex.org/I53964585"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016475369","display_name":"Charles Swanton","orcid":"https://orcid.org/0000-0002-4299-3018","observed_orcids":["https://orcid.org/0000-0002-4299-3018"]},"institutions":[{"id":"https://openalex.org/I2801081054","display_name":"The Francis Crick Institute","ror":"https://ror.org/04tnbqb63","country_code":"GB","type":"facility","lineage":["https://openalex.org/I2801081054"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"C. Swanton","raw_affiliation_strings":["Translational Cancer Therapeutics Department, The Francis Crick Institute, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Translational Cancer Therapeutics Department, The Francis Crick Institute, London, UK","institution_ids":["https://openalex.org/I2801081054"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5013716980","display_name":"Kevin Litchfield","orcid":"https://orcid.org/0000-0002-3725-0914","observed_orcids":["https://orcid.org/0000-0002-3725-0914"]},"institutions":[{"id":"https://openalex.org/I45129253","display_name":"University College London","ror":"https://ror.org/02jx3x895","country_code":"GB","type":"education","lineage":["https://openalex.org/I124357947","https://openalex.org/I45129253"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"K.R. Litchfield","raw_affiliation_strings":["Oncology, UCL Cancer Institute, London, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oncology, UCL Cancer Institute, London, UK","institution_ids":["https://openalex.org/I45129253"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3730,"currency":"USD","value_usd":3730},"apc_paid":{"value":3730,"currency":"USD","value_usd":3730},"fwci":0.1718,"has_fulltext":true,"cited_by_count":1,"citation_normalized_percentile":{"value":0.53112688,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"9","issue":null,"first_page":"103894","last_page":"103894"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.9824000000953674,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.015200000256299973,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10604","display_name":"RNA Research and Splicing","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nonsense-mediated-mrna-decay","display_name":"nonsense-mediated mRNA decay","score":0.8330000042915344},{"id":"https://openalex.org/keywords/b7-family","display_name":"B7 family","score":0.5490000247955322},{"id":"https://openalex.org/keywords/antitumor-immunity","display_name":"antitumor immunity","score":0.6919999718666077},{"id":"https://openalex.org/keywords/pharmacological-inhibition","display_name":"pharmacological inhibition","score":0.7649999856948853},{"id":"https://openalex.org/keywords/cancer-immunotherapy","display_name":"cancer immunotherapy","score":0.847000002861023},{"id":"https://openalex.org/keywords/tumor-immunogenicity","display_name":"tumor immunogenicity","score":0.6159999966621399}],"concepts":[{"id":"https://openalex.org/C2780868878","wikidata":"https://www.wikidata.org/wiki/Q1660197","display_name":"Immunogenicity","level":3,"score":0.8926674127578735},{"id":"https://openalex.org/C26291073","wikidata":"https://www.wikidata.org/wiki/Q310484","display_name":"Ex vivo","level":3,"score":0.8589615225791931},{"id":"https://openalex.org/C62923972","wikidata":"https://www.wikidata.org/wiki/Q600499","display_name":"Nonsense","level":3,"score":0.611186146736145},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.5842711925506592},{"id":"https://openalex.org/C207001950","wikidata":"https://www.wikidata.org/wiki/Q141124","display_name":"In vivo","level":2,"score":0.5455760955810547},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5427738428115845},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.5018830299377441},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.23741549253463745},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20848581194877625},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.18822678923606873},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18736550211906433},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.0},{"id":"https://openalex.org/C150903083","wikidata":"https://www.wikidata.org/wiki/Q7108","display_name":"Biotechnology","level":1,"score":0.0},{"id":"https://openalex.org/C104317684","wikidata":"https://www.wikidata.org/wiki/Q7187","display_name":"Gene","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.esmoop.2024.103894","doi":"https://doi.org/10.1016/j.esmoop.2024.103894","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2024.103894","pdf_url":"https://www.esmoopen.com/article/S2059-7029(24)01664-8/pdf","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"}],"best_oa_location":{"id":"doi:10.1016/j.esmoop.2024.103894","doi":"https://doi.org/10.1016/j.esmoop.2024.103894","is_oa":true,"landing_page_url":"https://doi.org/10.1016/j.esmoop.2024.103894","pdf_url":"https://www.esmoopen.com/article/S2059-7029(24)01664-8/pdf","source":{"id":"https://openalex.org/S4210217024","display_name":"ESMO Open","issn_l":"2059-7029","issn":["2059-7029"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-b","doyens","jufo-2","ki-jl-1","medline","norway-1","poland-40","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":"cc-by-nc-nd","license_id":"https://openalex.org/licenses/cc-by-nc-nd","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"ESMO Open","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4403537544.pdf","grobid_xml":"https://content.openalex.org/works/W4403537544.grobid-xml"},"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2054628179","https://openalex.org/W4282920273","https://openalex.org/W2086734209","https://openalex.org/W4379646242","https://openalex.org/W4391892181","https://openalex.org/W3015265197","https://openalex.org/W2886652494","https://openalex.org/W3103684935","https://openalex.org/W1999834081","https://openalex.org/W4417141979"],"abstract_inverted_index":{"Background:":[0],"B7":[1],"immune":[2,10],"checkpoint":[3],"proteins":[4,22,32],"are":[5],"important":[6],"regulators":[7],"of":[8],"antitumor":[9],"response,":[11],"and":[12,19,23,29],"they":[13],"can":[14],"also":[15],"mediate":[16],"oncogenic":[17],"signaling":[18],"cancer":[20,34],"development.B7-family":[21],"their":[24],"receptors":[25],"constitute":[26],"prognostic,":[27],"predictive":[28],"therapeutic":[30],"relevant":[31],"in":[33],"immunotherapies.":[35]},"counts_by_year":[{"year":2026,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2024-10-19T00:00:00"}